A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma (Q58024833)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma |
article |
Statements
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma (English)
Michael Millward
Paul Mainwaring
Ted Logan
Anna Pavlick
Ahmad A Tarhini
Steven J Kathman
Kevin H Laubscher
Mohammed M Dar
John M Kirkwood
1 February 2009